Alnylam Pharmaceuticals
ALNY
#638
Rank
C$45.07 B
Marketcap
$347.39
Share price
-0.59%
Change (1 day)
39.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: C$45.07 Billion

As of December 2024 Alnylam Pharmaceuticals has a market cap of C$45.07 Billion. This makes Alnylam Pharmaceuticals the world's 638th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024C$45.07 B41.47%
2023C$31.85 B-19.7%
2022C$39.67 B53.49%
2021C$25.84 B34.25%
2020C$19.25 B14.09%
2019C$16.87 B67.93%
2018C$10.04 B-36.56%
2017C$15.84 B266.89%
2016C$4.31 B-61.14%
2015C$11.11 B27.87%
2014C$8.69 B99.19%
2013C$4.36 B358.01%
2012C$0.95 B168.93%
2011C$0.35 B-15.13%
2010C$0.41 B-46.2%
2009C$0.77 B-37.71%
2008C$1.24 B5.28%
2007C$1.18 B28.13%
2006C$0.92 B207.78%
2005C$0.29 B73.36%
2004C$0.17 B

End of Day market cap according to different sources

On Dec 16th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

C$44.80 Billion
by Yahoo Finance info icon info icon
C$44.80 Billion
by CompaniesMarketCap info icon info icon
C$44.80 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$3.96 B-91.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$114.41 B 153.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.24 B-61.74%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.53 B-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.15 B-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$278.30 B 517.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$166.68 B 269.80%๐Ÿ‡ซ๐Ÿ‡ท France
C$26.63 B-40.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel